1,398
Views
35
CrossRef citations to date
0
Altmetric
Urology: Review article

The efficacy and safety of alpha-1 blockers for benign prostatic hyperplasia: an overview of 15 systematic reviews

, , , , &
Pages 279-287 | Accepted 10 Jan 2013, Published online: 29 Jan 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Claus G. Roehrborn, Martin M. Miner & Richard Sadovsky. (2018) Over-the-counter medication availability could augment self-management of male lower urinary tract symptoms. Postgraduate Medicine 130:5, pages 452-460.
Read now
Mustafa Dogan, Bunyamin Kutluksaman, Ibrahim Keles, Mustafa Karalar & Ahmet Omer Halat. (2017) The Effects of Systemic Alfuzosin and Tamsulosin Hydrochloride on Choroidal Thickness and Pupil Diameter Sizes in Cases with Benign Prostatic Hyperplasia. Current Eye Research 42:12, pages 1638-1643.
Read now
Gregory M. Asnis, Elishka Caneva & Margaret A. Henderson. (2016) A review of antidepressant-induced urinary hesitancy: a focus on levomilnacipran ER including two case presentations(5633). Expert Opinion on Drug Safety 15:5, pages 717-725.
Read now
Mohammad-Ali Haghsheno, Dan Mellström, Ralph Peeker, Jan Hammarsten, Mattias Lorentzon, Valter Sundh, Magnus Karlsson, Claes Ohlsson & Jan-Erik Damber. (2015) Lower urinary tract symptoms are associated with low levels of serum serotonin, high levels of adiponectin and fasting glucose, and benign prostatic enlargement. Scandinavian Journal of Urology 49:2, pages 155-161.
Read now
Sung Ryul Shim, Jae Heon Kim, Hoon Choi, Won Jin Lee, Hae Joon Kim, Min Young Bae, Sung Dong Hwang, Khae Hwan Kim, Jae Hyun Bae & Sang Jin Yoon. (2015) General effect of low-dose tamsulosin (0.2 mg) as a first-line treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia: a systematic review and meta-analysis. Current Medical Research and Opinion 31:2, pages 353-365.
Read now

Articles from other publishers (30)

Santosh Kumar S C, Raveendran R & Rajesh Nachiappa Ganesh. (2022) Cleistanthins A and B Ameliorate Testosterone-Induced Benign Prostatic Hyperplasia in Castrated Rats by Regulating Apoptosis and Cell Differentiation. Cureus.
Crossref
Sidiane B. da Silva, Sidney G.D. Feitosa, Silvia M. de L. Alves, Ruth C.A. Santos, Janaína V. dos Anjos & Alice V. Araújo. (2022) A Concise and Useful Guide to Understand How Alpha1 Adrenoceptor Antagonists Work. Mini-Reviews in Medicinal Chemistry 22:18, pages 2383-2405.
Crossref
Subin Oh, Moon Ho Do, Jin A Shin, Min Jee Lee, Hua Li, Su Yeon Cho & Jong-Moon Jeong. (2022) A Combination of Natural Products, BenPros (Green Tea Extract, Soybean Extract and Camellia Japonica Oil), Ameliorates Benign Prostatic Hyperplasia. Applied Sciences 12:12, pages 6121.
Crossref
Dalia Mahmoud Abdelmonem Elsherbini, Hailah M. Almohaimeed, Mohamed El-Sherbiny, Zuhair M. Mohammedsaleh, Nehal M. Elsherbiny, Sami A. Gabr & Hasnaa Ali Ebrahim. (2022) Origanum majorana L. Extract Attenuated Benign Prostatic Hyperplasia in Rat Model: Effect on Oxidative Stress, Apoptosis, and Proliferation. Antioxidants 11:6, pages 1149.
Crossref
Milad Allahgholi, Hossein Rahmani, Delaram Javdani, Zahra Sadeghi-Adl, Andreas Bender, Dezsö Módos & Gerhard Weiss. (2022) DDREL: From drug-drug relationships to drug repurposing. Intelligent Data Analysis 26:1, pages 221-237.
Crossref
Murat Akgül, Cenk Yazıcı, Timuçin Şipal & Ersan Arda. (2021) The clinical significance of abnormal ejaculation by silodosin. Is it important?. Andrologia 53:7.
Crossref
Hugo López-Ramos, Carlos Latorre, Germán Patiño & Juliana Arenas. (2021) Guía de manejo Hiperplasia Prostática Benigna (SCU 2021). Revista Urología Colombiana / Colombian Urology Journal 30:02, pages 145-152.
Crossref
Claus G. Roehrborn, Franklin C. Lowe, Marc Gittelman, Anne Esler, Kristin D. Drda, Jan M. Wruck & Anna E. Verbeek. (2020) An Actual Use Study of Tamsulosin in Men with Bothersome Urinary Symptoms in a Simulated Over-the-Counter Setting. Urology Practice 7:1, pages 14-20.
Crossref
Claus G. Roehrborn, Franklin C. Lowe, Marc Gittelman, Jan M. Wruck & Anna E. Verbeek. (2020) Over-the-Counter Tamsulosin for Men with Urinary Symptoms: A Simulated Self-Selection Study. Urology Practice 7:1, pages 7-13.
Crossref
Manuel F. Schubert, Jared R. Thomas, Jacob Yashar, John J. Lee, Andrew G. Urquhart, Joel J. Gagnier & Aidin Eslam Pour. (2019) Post-operative urinary retention after lower extremity arthroplasty and the peri-operative role of selective alpha-1 adrenergic blocking agents in adult male patients: a propensity-matched retrospective cohort study. International Orthopaedics 44:1, pages 39-44.
Crossref
Manuel F. Schubert, Jared R. Thomas, Joel J. Gagnier, Caitlin M. McCarthy, John J. Lee, Andrew G. Urquhart & Aidin Eslam Pour. (2019) The AAHKS Clinical Research Award: Prophylactic Tamsulosin Does Not Reduce the Risk of Urinary Retention Following Lower Extremity Arthroplasty: A Double-Blinded Randomized Controlled Trial. The Journal of Arthroplasty 34:7, pages S17-S23.
Crossref
Claus G. Roehrborn, Franklin C. Lowe, Marc Gittelman, Jan M. Wruck & Anna E. Verbeek. (2019) Management of Male Lower Urinary Tract Symptoms in a Simulated, Over-the-Counter Setting: An Exploratory Study of Tamsulosin. Drugs & Aging 36:2, pages 179-188.
Crossref
César Augusto Guevara-Cuellar, Elizabeth Parody-Rúa, Herney Andres Garcia-Perdomo & Andrea Arenas-Duque. (2018) Cost-Effectiveness of Combination Therapy Versus Monotherapy in Benign Prostatic Hyperplasia: A Colombian Experience. Value in Health Regional Issues 17, pages 174-182.
Crossref
Steven A. Kaplan & Bilal I. Chughtai. (2018) Safety of Tamsulosin: A Systematic Review of Randomized Trials with a Focus on Women and Children. Drug Safety 41:9, pages 835-842.
Crossref
Il-Gyu Ko, Lakkyong Hwang, Jun-Jang Jin, Sang-Hoon Kim, Jin Hee Han, Jung Won Jeon & Sung Tae Cho. (2018) Add-on Therapy With the α-Blockers Tamsulosin and Naftopidil Improves Voiding Function by Enhancing Neuronal Activity in Prostatic Hyperplasia Rats. International Neurourology Journal 22:1, pages 20-29.
Crossref
Yunu Jung, Jinbong Park, Hye-Lin Kim, Dong-Hyun Youn, JongWook Kang, Seona Lim, Mi-Young Jeong, Gautam Sethi, Sung-Joo Park, Kwang Seok Ahn & Jae-Young Um. (2017) Vanillic acid attenuates testosterone-induced benign prostatic hyperplasia in rats and inhibits proliferation of prostatic epithelial cells. Oncotarget 8:50, pages 87194-87208.
Crossref
J. Castiñeiras, J.M. Cózar, B. Miñana, F.J. Brenes, F. Brotons, A. Fernández-Pro, J.A. Martín, Mª.L. Martínez-Berganza & J.M. Molero. (2016) WITHDRAWN: Documento de consenso Pautas de actuación y seguimiento del varón con Síntomas del Tracto Urinario Inferior secundarios a Hiperplasia Prostática Benigna. Actas Urológicas Españolas.
Crossref
A. Alcántara Montero. (2016) Silodosina en el tratamiento de los síntomas del tracto urinario inferior en el varón por hiperplasia benigna de próstata: enfoque estándar y uso en la «vida real». Revista Mexicana de Urología 76:6, pages 352-359.
Crossref
F.J. Brenes Bermúdez, F. Brotons Muntó, J. Castiñeiras Fernández, J.M. Cozar Olmo, A. Fernández-Pro Ledesma, J.A. Martín Jiménez, M.L. Martínez-Berganza Asensio, B. Miñana López & J.M. Molero García. (2016) Documento de consenso sobre pautas de actuación y seguimiento del varón con síntomas del tracto urinario inferior secundarios a hiperplasia prostática benigna. SEMERGEN - Medicina de Familia 42:8, pages 547-556.
Crossref
Aleksandra Rak, Vittorio Canale, Krzysztof Marciniec, Paweł Żmudzki, Magdalena Kotańska, Joanna Knutelska, Agata Siwek, Gabriela Stachowicz, Marek Bednarski, Leszek Nowiński, Małgorzata Zygmunt, Paweł Zajdel & Jacek Sapa. (2016) Arylsulfonamide derivatives of (aryloxy)ethyl pyrrolidines and piperidines as α 1 -adrenergic receptor antagonist with uro-selective activity. Bioorganic & Medicinal Chemistry 24:21, pages 5582-5591.
Crossref
Francisco José Brenes Bermúdez, Francisco Brotons Muntó, Jesús Castiñeiras Fernández, José Manuel Cozar Olmo, Antonio Fernández-Pro Ledesma, Juan Antonio Martín Jiménez, M. Lourdes Martínez-Berganza Asensio, Bernardino Miñana López & José María Molero García. (2016) Documento de consenso sobre pautas de actuación y seguimiento del varón con síntomas del tracto urinario inferior secundarios a hiperplasia prostática benigna. Medicina General y de Familia 5:3, pages 97-106.
Crossref
Sung Ryul ShimJae Heon KimIn Ho ChangIn Soo ShinSung Dong HwangKhae Hwan KimSang Jin YoonYun Seob Song. (2016) Is Tamsulosin 0.2 mg Effective and Safe as a First-Line Treatment Compared with Other Alpha Blockers?: A Meta-Analysis and a Moderator Focused Study. Yonsei Medical Journal 57:2, pages 407.
Crossref
Claus G. Roehrborn, Franklin C. Lowe, Marc Gittelman, Jan M. Wruck & Anna E. Verbeek. (2016) Feasibility of an Alternative Option for the Management of Male Lower Urinary Tract Symptoms. Journal of Urology 195:1, pages 125-130.
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 201 214 .
Jenna L. Foster, Phillip L. Mohorn & Alejandro J. Luis. (2015) Constipation-Induced Acute Urinary Retention in the Intensive Care Unit. The American Surgeon 81:8, pages 316-318.
Crossref
Jin-Qiu Yuan, Chen Mao, Samuel Yeung-Shan Wong, Zu-Yao Yang, Xiao-Hong Fu, Xiao-Yu Dai & Jin-Ling Tang. (2015) Comparative Effectiveness and Safety of Monodrug Therapies for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia. Medicine 94:27, pages e974.
Crossref
Ariadne Gutiérrez, Rafael Gámez, Miriam Noa, Rosa Mas, Maikel Valle, Nilda Mendoza, Carlos Nodal, Yohani Pérez, Ámbar Oyarzábal, Isury Bucarano, Edy Goicochea, Sonia Jiménez & Haydee García. (2015) Long-Term (24 Months) Carcinogenicity Study of D-004, a Lipid Extract From Roystonea regia Fruits, in Sprague Dawley Rats . International Journal of Toxicology 34:2, pages 138-150.
Crossref
Altaf Mangera. (2015) Update summarising the conclusions of the international consultation on male lower urinary tract symptoms. World Journal of Clinical Urology 4:2, pages 83.
Crossref
Nathan Hale, Kellen Choi & Joshua Lohri. (2014) Primary Care Evaluation and Treatment of Men With Lower Urinary Tract Symptoms. Journal of Osteopathic Medicine 114:7, pages 566-571.
Crossref
F. Dal Moro. (2013) The dark knight of syncope: the urologist!. Journal of Internal Medicine 274:3, pages 291-292.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.